Retinoic Acid (Retin-A) and Peppermint Oil are well known and there has been much discussion about how they work and if they work at all. Retin-A is said to help minoxidil absorption whilst Peppermint Oil helps by acting as a vasodilator, my initial thoughts when researching was Retin-A helped due to its PTGDS inhibition and Peppermint Oil via Rosmarinic acid although I have to concede that the latter may not be the case when using peppermint essential oils.
However I now believe there is relation to IL-6. There was a study on IL-6 that has been touched on before http://www.hairlosstalk.com/interac...6-may-be-one-of-the-factors-involved-in-the-p
Re-quoting the study http://www.ncbi.nlm.nih.gov/pubmed/21881585
According to this IL-6 is elevated in the balding DP cells and adding DHT to DP cells causes IL-6 upregulation. rhIL-6 causes inhibited hair shaft elongation (miniaturization) therefore IL-6 is bad. This recent study (http://onlinelibrary.wiley.com/doi/10.1111/exd.12896/pdf) however suggests that IL-6 when present during wounding is good but I don't think these two observations of IL-6 are contradictory as:
So what does this have to do with Retin-A and Peppermint Oil? I came across this study today: http://www.ncbi.nlm.nih.gov/pubmed/2033252
Additionally there is also a link between Vitamin E and IL-6 due to its anti inflammatory properties which may be worth looking into.
However I now believe there is relation to IL-6. There was a study on IL-6 that has been touched on before http://www.hairlosstalk.com/interac...6-may-be-one-of-the-factors-involved-in-the-p
Re-quoting the study http://www.ncbi.nlm.nih.gov/pubmed/21881585
Autocrine and paracrine factors are produced by balding dermal papilla (DP) cells following dihydrotestosterone (DHT)-driven alterations and are believed to be key factors involved in male pattern baldness. Herein we report that the IL-6 is upregulated in balding DP cells compared with non-balding DP cells. IL-6 was upregulated 3 hours after 10-100 nM DHT treatment, and ELISA showed that IL-6 was secreted from balding DP cells in response to DHT. IL-6 receptor (IL-6R) and glycoprotein 130 (gp130) were expressed in follicular keratinocytes, including matrix cells. Recombinant human IL-6 (rhIL-6) inhibited hair shaft elongation and suppressed proliferation of matrix cells in cultured human hair follicles. Moreover, rhIL-6 injection into the hypodermis of mice during anagen caused premature onset of catagen. Taken together, our data strongly suggest that DHT-inducible IL-6 inhibits hair growth as a paracrine mediator from the DP.
According to this IL-6 is elevated in the balding DP cells and adding DHT to DP cells causes IL-6 upregulation. rhIL-6 causes inhibited hair shaft elongation (miniaturization) therefore IL-6 is bad. This recent study (http://onlinelibrary.wiley.com/doi/10.1111/exd.12896/pdf) however suggests that IL-6 when present during wounding is good but I don't think these two observations of IL-6 are contradictory as:
It is plausible that IL-6 presence where there is no trauma is detrimental to hair follicles.IL-6 is secreted by T cells and macrophages to stimulate immune response, e.g. during infection and after trauma, especially burns or other tissue damage leading to inflammation.
So what does this have to do with Retin-A and Peppermint Oil? I came across this study today: http://www.ncbi.nlm.nih.gov/pubmed/2033252
It would seem that Retin-A down regulates the number of IL-6 receptors whilst Menthol (the bulk component of peppermint oil) suppresses IL-6 receptor expression. So we are basically inhibiting IL-6 by using these two which in the case of IL-6 produced by DHT attaching to DP cells is a good thing, however we will also inhibit IL-6 produced as a reaction to wounds which is a bad thing. The other consideration is that there are limits to how much Retin-A and Methol can be applied to skin and as such it may be the limiting factor for both, although without a proper study it is impossible to know.In this report we demonstrate that retinoic acid (RA) down-regulated the number of IL-6R on human leukocyte cell lines, including the myeloma cell line AF10, and two B cell hybridomas that correspond to cells at earlier stages of B cell development. Using AF10 cells, whose growth was determined to be mediated by the autocrine action of IL-6, we found that RA reduction of IL-6R was concentration-dependent over a range of 10(-11) to 10(-5) M and corresponded to the ability of the retinoid to inhibit cell proliferation. The down-regulation of IL-6R number by RA was accompanied by reduced IL-6R mRNA expression. RA did not affect endogeneous IL-6 synthesis or secretion from AF10 cells. However, addition of exogenous rIL-6 could overcome RA-induced growth inhibition. Menthol, a structurally unrelated compound to RA, also suppressed IL-6R expression and, correspondingly, inhibited cell growth. Taken together, our results suggest that the antiproliferative action of RA on AF10 cells is caused by reduction of IL-6R expression and subsequent inhibition of IL-6-mediated autocrine growth. These findings suggest the possibility that down-regulation of IL-6R is a means by which RA can modulate immune function.
Additionally there is also a link between Vitamin E and IL-6 due to its anti inflammatory properties which may be worth looking into.